MAY 29, 2017 7:12 AM PDT

Is A Drug From Last Century The New Autism Hope?

There is no known cure or treatment for autism, but that doesn’t stop researchers from looking for any possible options to treat the disorder that is now estimated to affect 1 in 68 children. A small, randomized Phase I/II clinical trial (SAT1 at the University of California San Diego School of Medicine suggests that a drug that’s been around for over a century and was originally developed to treat African Sleeping Sickness, could be a possible treatment for patients on the autism spectrum.

The goal of this very small research study was to investigate the cell danger hypothesis as a possible unifying theory that contributes to the cause and origins of autism spectrum disorders. The study, published in the journal Annals of Clinical and Translational Neurology, looked at the drug Suramin, which was developed over 100 years ago to treat African sleeping sickness. In the study at the UC San Diego School of Medicine, study participants were given a single IV dose of the drug suramin.

In five boys with autism who took part in the study, measurable, but temporary improvement was shown. The “cell danger response theory,” suggests that autism has its roots in metabolic function and is therefore treatable with drugs that affect metabolism. The research study was a double-blind, placebo-controlled safety study involving 10 boys, ages 5 to 14 years, all diagnosed with ASD. Five of the 10 boys received a single, intravenous infusion of suramin,. The other five boys in the control group were dosed with a placebo. The trial in these boys was a follow up to earlier testing on a mouse model. 

All five boys who received the suramin infusion displayed improvements in language and social behavior and showed a reduction in repetitive “stimming” behaviors.  This improvement was based on baseline questionnaires and assessments filled out by parents of the study participants before the drug was administered and then evaluation with the Autism Diagnostic Observation Schedule, 2nd edition (ADOS-2), the Expressive One Word Picture Vocabulary Testing (EOWPWT), the Aberrant Behavior Checklist (ABC), the Autism Treatment Evaluation Checklist (ATEC), the Repetitive Behavior Questionnaire (RBQ) and the Clinical Global Impression (CGI). These are all standard and respected assessment tools for evaluating ASD symptoms in children.

Parents of the children also reported better eye contact and improvement in speech, even though they were not aware of whether or not their child had received suramin or the placebo. Study first author Robert K. Naviaux, MD, PhD, professor of medicine, pediatrics and pathology at UC San Diego School of Medicine believes that autism, as well as other disorders are related to  metabolic dysfunction or impaired communication between cells in the brain, gut and immune system. The “cell danger response” is a reaction that occurs when cells harden their membranes in an effort to protect themselves against stress or injury.  Naviaux explained, “This prevents completion of the natural healing cycle and can permanently alter the way the cell responds to the world. When this happens, cells behave as if they are still injured or in imminent danger, even though the original cause of the injury or threat has passed. At the molecular level, cellular homeostasis or equilibrium is altered, creating an abnormal cellular response that leads to chronic disease. When this happens during early child development, it causes autism and many other chronic childhood disorders.” The drug suramin is thought to work by inhibiting this response.

While the study at UC San Diego was small, two of the non-verbal children in the study who received suramin spoke for the first time in their lives. When used for African sleeping sickness, suramin can result in severe side effects, but in the ASD study, the dose was low and did not result in anything more than a passing rash. While the results were encouraging, the effect of the drug was temporary. Larger trials are needed to further evaluate the drug and its possible benefits for children on the autism spectrum. The video below has more information, take a look.

Sources: UC San Diego School of Medicine, San Diego Union Tribune, Naviaux Lab, Annals of  Clinical and Translational Neurology 

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
MAR 07, 2020
Neuroscience
MAR 07, 2020
Speech and Melodies Processed in Different Parts of Brain
Songbirds are able to separate sounds by processing them according to two distinct categories- time and frequency. To un ...
APR 24, 2020
Drug Discovery & Development
APR 24, 2020
Teenage Cannabis Use May Prime the Brain to Enjoy Cocaine
New research has found that teenage cannabis use may make the brain more susceptible to the effects of cocaine. "It ...
APR 23, 2020
Neuroscience
APR 23, 2020
'Aha' Moments Trigger Orgasmic Brain Signals
New research has shown that gaining a new insight, also known as an ‘aha’ moment, induces signaling patterns ...
MAY 02, 2020
Immunology
MAY 02, 2020
Cellular "Cleaning Crews" Get Busy During Spinal Cord Injury
  Nerve cells transmit and receive information traversing the human body in the form of electrical impulses. These ...
MAY 03, 2020
Cell & Molecular Biology
MAY 03, 2020
How One Protein is Linked to Three Different Brain Disorders
The accumulation of aberrant, misfolded proteins is a known feature of several different kinds of brain diseases.
MAY 19, 2020
Cannabis Sciences
MAY 19, 2020
Does Cannabinoid Deficiency Cause Common Illness?
Cannabis products are a godsend for many suffering from chronic illness. They are able to resolve multiple issues from d ...
Loading Comments...